| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.98.6.535 |
| P698 | PubMed publication ID | 9714110 |
| P2093 | author name string | Díez J | |
| Fernández J | |||
| Gil MJ | |||
| Varo N | |||
| Mayor G | |||
| Monreal I | |||
| Laviades C | |||
| P433 | issue | 6 | |
| P921 | main subject | essential hypertension | Q988405 |
| P304 | page(s) | 535-540 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Abnormalities of the extracellular degradation of collagen type I in essential hypertension | |
| P478 | volume | 98 |
| Q35582488 | Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis |
| Q37955866 | An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage |
| Q33637776 | Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study |
| Q82793514 | Associations between collagen synthesis and degradation and aortic function in arterial hypertension |
| Q38354648 | Basal and oxidative stress-induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortic valve patients |
| Q85822202 | Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension |
| Q40300916 | Biochemical evidence of myocardial fibrosis in veteran endurance athletes |
| Q38040163 | Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease |
| Q35777180 | Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. |
| Q35992781 | Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy |
| Q35582221 | Changes in the myocardial interstitium and contribution to the progression of heart failure |
| Q64239235 | Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population |
| Q58621956 | Circulating levels of matrix metalloproteinases in heart transplant recipients |
| Q50452526 | Computational model of collagen turnover in carotid arteries during hypertension. |
| Q37090982 | Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. |
| Q36203117 | Disruptions and detours in the myocardial matrix highway and heart failure |
| Q47668936 | Dynamic assessment of myocardial involvement in patients with end-stage renal disease by ultrasonic tissue characterization and serum markers of collagen metabolism. |
| Q36749281 | ECM remodeling in hypertensive heart disease |
| Q44641066 | Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats |
| Q81709672 | Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction |
| Q74588037 | Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy |
| Q51831372 | Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. |
| Q43230192 | Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension |
| Q88453278 | Epigenetics of Aberrant Cardiac Wound Healing |
| Q36516254 | Ethnic heterogeneity in the longitudinal effects of placental vascular blood flow on birthweight |
| Q84963235 | Exercise training enhances elastin, fibrillin and nitric oxide in the aorta wall of spontaneously hypertensive rats |
| Q37616705 | Extracellular matrix alterations in hypertensive vascular remodeling |
| Q37464914 | Extracellular matrix fibrotic markers in heart failure |
| Q35187788 | Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions |
| Q34294293 | Extracellular matrix remodeling in the vascular wall |
| Q35158979 | Fibrinolytic function and atrial fibrillation |
| Q24644869 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
| Q28367770 | Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q50916304 | Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. |
| Q36009930 | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease |
| Q73131097 | Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy |
| Q38014069 | Matrix metalloproteinases |
| Q37195730 | Matrix metalloproteinases and cardiovascular diseases. |
| Q36477722 | Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease |
| Q37993746 | Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications |
| Q33872836 | Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease |
| Q35636530 | Matrix metalloproteinases: pathways of induction by bioactive molecules |
| Q35936620 | Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. |
| Q42130552 | Metalloproteinase-3 genotype as a predictor of cardiovascular risk in hypertensive adolescents |
| Q35046512 | Molecular mechanisms of angiotensin II-induced vascular injury. |
| Q46664447 | Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance |
| Q44307218 | Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment |
| Q34138706 | Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction |
| Q36748065 | Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease |
| Q33689229 | Redox signaling, vascular function, and hypertension |
| Q35395483 | Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition |
| Q34028447 | Regulation of matrix proteins and impact on vascular structure |
| Q37312630 | Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community |
| Q35151494 | Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk |
| Q36392895 | Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy |
| Q37899085 | Role of various proteases in cardiac remodeling and progression of heart failure |
| Q36473364 | Screening for ventricular remodeling |
| Q40109102 | Serum anti-collagen type IV IgM antibodies and development of diabetic nephropathy in diabetics with essential hypertension. |
| Q89623456 | The Role of the Renin-Angiotensin System and Vitamin D in Keloid Disorder-A Review |
| Q33904413 | The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases |
| Q81791292 | The relationship between pulse wave velocity and indexes of collagen synthesis in hypertensive patients, according to the level of systolic blood pressure |
| Q35686798 | The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study |
| Q28211259 | Therapeutic potential of breakers of advanced glycation end product–protein crosslinks |
| Q81563886 | Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children |
Search more.